Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» weight loss
weight loss
Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns
CBS News
Thu, 05/15/25 - 10:47 am
weight loss
obesity
GLP-1 agonists
David Kessler
Novo’s Wegovy inches closer to becoming first FDA-approved GLP-1 weight-loss pill
BioSpace
Mon, 05/5/25 - 11:29 am
Novo Nordisk
Wegovy
FDA
obesity
weight loss
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
Motley Fool
Sun, 05/4/25 - 12:09 pm
Eli Lilly
Novo Nordisk
Viking Therapeutics
CVS Health
pharma stocks
weight loss
obesity
WHO set to back use of weight-loss drugs for adults globally, raises cost issue
MSN/Reuters
Thu, 05/1/25 - 10:28 pm
WHO
weight loss
obesity
Novo Nordisk
Eli Lilly
Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
Yahoo/Reuters
Fri, 03/21/25 - 11:42 am
gene therapy
rare disease
cancer
obesity
weight loss
drug development
Patients scramble as cheaper obesity drug alternatives disappear
NPR
Thu, 03/20/25 - 11:15 am
patients
tirzepatide
weight loss
compounding pharmacies
Zepbound
Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India, at $50 for 5 mg vial
MSN/Reuters
Thu, 03/20/25 - 10:18 am
Eli Lilly
Mounjaro
India
weight loss
Novo Nordisk
Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients
Fierce Pharma
Wed, 03/5/25 - 11:59 am
Novo Nordisk
DTC
Wegovy
Eli Lilly
weight loss
drug compounding
As Money Pours Into Weight Loss Drugs, Physicians Prioritize Efficacy, Access
BioSpace
Thu, 02/27/25 - 11:18 am
physicians
obesity
weight loss
heart disease
GLP-1 agonists
drug pricing
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
CNBC
Tue, 02/25/25 - 11:14 am
Eli Lilly
Zepbound
weight loss
LillyDirect
Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile
US News and World Report
Thu, 02/20/25 - 06:07 pm
Eli Lilly
weight loss
obesity
clinical trials
orforglipron
3 trial readouts that could shake up the obesity market this year
Pharma Voice
Wed, 01/8/25 - 11:15 am
obesity
weight loss
Metsera
MET-097i
Skye Bioscience
nimacimab
Eli Lilly
orforglipron
clinical trials
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Fierce Biotech
Tue, 01/7/25 - 06:57 pm
Metsera
GLP-1 agonist
weight loss
MET-097i
Novo’s next-gen obesity drug misses expectations in closely watched trial
BioPharma Dive
Fri, 12/20/24 - 11:34 am
Novo Nordisk
CagriSema
clinical trials
weight loss
A new GLP-1 opportunity for pharma: Supporting patients’ emotional barriers to weight loss
Pharmaphorum
Wed, 12/18/24 - 11:14 am
patients
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial
BioPharma Dive
Wed, 12/4/24 - 11:02 am
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
clinical trials
weight loss
obesity
Weight-loss drug coverage rises among largest US employers, Mercer survey finds
MSN/Reuters
Wed, 11/20/24 - 11:30 am
employers
coverage
insurance
weight loss
obesity
Drugmakers and pharmacists battle over who gets to make obesity drugs
NPR
Wed, 11/20/24 - 11:21 am
Novo Nordisk
Eli Lilly
obesity
weight loss
GLP-1 agonists
compounded drugs
Novo’s Wegovy Launched in China at a Fraction of US Price
BioSpace
Mon, 11/18/24 - 11:28 am
Novo Nordisk
Wegovy
Cina
weight loss
GLP-1 agonists
Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »